Thread Raises $50M in Funding

Thread, a Tustin, Calif.-based provider of decentralized clinical research, reportedly raised $50m in funding.

Backers included Water Street Healthcare Partners and JLL Partners.

The company intends to use the funds to continue to expand operations and its business reach.

Led by John Reites, President, and Sean Vassilaros, COO, Thread is a provider of a proprietary, decentralized research platform and suite of supporting services used by biopharma, CROs and life science organizations to remotely capture data from participants and sites during, in-between and in lieu of in-clinic visits. It provides a platform and supporting services for customers to reduce study launch timelines, study budgets with Virtual Visits and bring studies from the clinic to patients’ homes. The company provides key features such as eConsent, eCOA/ePRO, sensors, reminders and telehealth Virtual Visits to support remote data capture, hybrid virtual studies and fully decentralized studies in key therapeutic areas.



Join the discussion